{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:54:51Z","timestamp":1789102491259,"version":"build-2803163510"},"reference-count":144,"publisher":"IMR Press","issue":"5","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Inborn errors of immunity (IEIs) are a group of more than 485 disorders that impair immune development and function with variable reported incidence, severity, and clinical phenotypes. A subset of IEIs blend increased susceptibility to infection, autoimmunity, and malignancy and are known collectively as primary immune regulatory disorders (PIRDs). Programmed cell death, or apoptosis, is crucial for maintaining the balance of lymphocytes. Genetic-level identification of several human inherited diseases with impaired apoptosis has been achieved, such as autoimmune lymphoproliferative syndrome (ALPS), caspase-8 deficiency state (CEDS), X-linked lymphoproliferative syndrome (XLP), and Janus kinase (JAK)\/signal transducer and activator of transcription (STAT) pathway disorders. The consequences of this disease are manifested by abnormal lymphocyte accumulation, resulting in clinical features such as lymphadenopathy, hepatomegaly, splenomegaly, and an increased risk of lymphoma. Additionally, these disorders are often associated with autoimmune disease, particularly involving blood cells. Understanding the molecular pathogenesis of these conditions has provided critical insights into the signaling pathways that regulate apoptosis and lymphocyte activation, shedding light on mechanisms of immune dysregulation. This review focuses on the intersection between apoptosis, autoimmunity, and lymphoproliferation, discussing how dysregulation contributes to the development of these immune disorders. These conditions are characterized by excessive lymphocyte accumulation, autoimmunity, and\/or immunodeficiency. Understanding their molecular pathogenesis has offered new insights into the signaling mechanisms that regulate apoptosis and lymphocyte activation.<\/jats:p>","DOI":"10.31083\/fbl27231","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:33:04Z","timestamp":1749040384000},"source":"Crossref","is-referenced-by-count":2,"title":["Inborn Errors of Immunity in Apoptosis"],"prefix":"10.31083","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1889-5813","authenticated-orcid":true,"given":"Nadia","family":"Makkoukdji","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Jackson Memorial Hospital, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9320-1570","authenticated-orcid":true,"given":"Travis","family":"Satnarine","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Jackson Memorial Hospital, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana Xavier","family":"de Almeida","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Jackson Memorial Hospital, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5785-4044","authenticated-orcid":true,"given":"Matthew","family":"Wyke","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Jackson Memorial Hospital, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0238-4706","authenticated-orcid":true,"given":"Iris H.","family":"Kim","sequence":"first","affiliation":[{"name":"University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2066-9476","authenticated-orcid":true,"given":"Gary I.","family":"Kleiner","sequence":"first","affiliation":[{"name":"Division of Allergy and Immunology, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3078-0998","authenticated-orcid":true,"given":"Melissa","family":"Gans","sequence":"first","affiliation":[{"name":"Division of Allergy and Immunology, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Min B. Spontaneous T Cell Proliferation: A Physiologic Process to Create and Maintain Homeostatic Balance and Diversity of the Immune System. Frontiers in Immunology. 2018; 9: 547.","DOI":"10.3389\/fimmu.2018.00547."},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Opferman JT. Apoptosis in the development of the immune system. Cell Death and Differentiation. 2008; 15: 234\u2013242.","DOI":"10.1038\/sj.cdd.4402182."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Su HC, Oliveira JB, Lenardo MJ. 14 - Programmed cell death in lymphocytes. In Rich RR, Fleisher TA, Shearer WT, Schroeder HW, Frew AJ, Weyand CM (eds.) Clinical Immunology (Third Edition) (pp. 225\u2013234). Mosby: USA. 2008.","DOI":"10.1016\/B978-0-323-04404-2.10014-4"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Elmore S. Apoptosis: a review of programmed cell death. Toxicologic Pathology. 2007; 35: 495\u2013516.","DOI":"10.1080\/01926230701320337."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Sikora E, Brzezi\u0144ska A. Activation-Induced Cell Death of T Cells in Human Aging. In Fulop T, Franceschi C, Hirokawa K, Pawelec G (eds.) Handbook of Immunosenescence: Basic Understanding and Clinical Implications (pp. 533\u2013552). Springer International Publishing: Switzerland. 2019.","DOI":"10.1007\/978-3-319-99375-1_15"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Fritsch M, G\u00fcnther SD, Schwarzer R, Albert MC, Schorn F, Werthenbach JP, et al. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature. 2019; 575: 683\u2013687.","DOI":"10.1038\/s41586-019-1770-6."},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infection and Immunity. 2005; 73: 1907\u20131916.","DOI":"10.1128\/IAI.73.4.1907-1916.2005."},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity. Journal of Clinical Immunology. 2022; 42: 1508\u20131520.","DOI":"10.1007\/s10875-022-01352-z."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Miano M, Cappelli E, Pezzulla A, Ven\u00e8 R, Palmisani E, Grossi A, et al. FAS-Mediated Apoptosis Assay in Patients with ALPS-like Phenotype Carrying CASP10 Mutations. Blood. 2018; 132: 4960.","DOI":"10.1182\/blood-2018-99-118180."},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Sneller MC, Wang J, Dale JK, Strober W, Middelton LA, Choi Y, et al. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood. 1997; 89: 1341\u20131348.","DOI":"10.1182\/blood.V89.4.1341"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Batlle-Mas\u00f3 L, Garcia-Prat M, Parra-Mart\u00ednez A, Franco-Jarava C, Aguil\u00f3-Cucurull A, Velasco P, et al. Detection and evolutionary dynamics of somatic FAS variants in autoimmune lymphoproliferative syndrome: Diagnostic implications. Frontiers in Immunology. 2022; 13: 1014984.","DOI":"10.3389\/fimmu.2022.1014984."},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Shah S, Wu E, Rao VK, Tarrant TK. Autoimmune lymphoproliferative syndrome: an update and review of the literature. Current Allergy and Asthma Reports. 2014; 14: 462.","DOI":"10.1007\/s11882-014-0462-4."},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Makkoukdji N, Pundit V, Wyke M, Giraldo J, Satnarine T, Kleiner GI, et al. Targeted treatments for immune dysregulation in inborn errors of immunity. Exploration of Immunology. 2024; 4: 218\u2013237.","DOI":"10.37349\/ei.2024.00138."},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Hafezi N, Zaki-Dizaji M, Nirouei M, Asadi G, Sharifinejad N, Jamee M, et al. Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review. Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology. 2021; 32: 1519\u20131532.","DOI":"10.1111\/pai.13535."},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Tang Y, Wang H, Zhao H, Jin S, Wu J. RAS-associated Autoimmune Leukoproliferative Disease (RALD-KRAS) Consistent with the Clinical Diagnosis of Rosai-Dorfman Disease: A 15-year Follow-up. Journal of Clinical Immunology. 2024; 44: 123.","DOI":"10.1007\/s10875-024-01728-3."},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Neven Q, Boulanger C, Bruwier A, de Ville de Goyet M, Meyts I, Moens L, et al. Clinical Spectrum of Ras-Associated Autoimmune Leukoproliferative Disorder (RALD). Journal of Clinical Immunology. 2021; 41: 51\u201358.","DOI":"10.1007\/s10875-020-00883-7."},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Teachey DT. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome. Current Opinion in Pediatrics. 2012; 24: 1\u20138.","DOI":"10.1097\/MOP.0b013e32834ea739."},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Wang W, Zhou Y, Zhong L, Wang L, Tang X, Ma M, et al. RAS-associated Autoimmune Leukoproliferative disease (RALD) manifested with early-onset SLE-like syndrome: a case series of RALD in Chinese children. Pediatric Rheumatology Online Journal. 2019; 17: 55.","DOI":"10.1186\/s12969-019-0346-1."},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 2006; 25: 745\u2013755.","DOI":"10.1016\/j.immuni.2006.09.009."},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Dotta L, Todaro F, Baronio M, Giacomelli M, Pinelli M, Giambarda M, et al. Patients with STAT1 Gain-of-function Mutations Display Increased Apoptosis which is Reversed by the JAK Inhibitor Ruxolitinib. Journal of Clinical Immunology. 2024; 44: 85.","DOI":"10.1007\/s10875-024-01684-y."},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Ye F, Zhang W, Dong J, Peng M, Fan C, Deng W, et al. A novel STAT1 loss-of-function mutation associated with Mendelian susceptibility to mycobacterial disease. Frontiers in Cellular and Infection Microbiology. 2022; 12: 1002140.","DOI":"10.3389\/fcimb.2022.1002140."},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Tolomeo M, Cavalli A, Cascio A. STAT1 and Its Crucial Role in the Control of Viral Infections. International Journal of Molecular Sciences. 2022; 23: 4095.","DOI":"10.3390\/ijms23084095."},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Anastas V, Wang W, Price S, Zhao Z, Rao VK, Calvo KR. Indolent Phenotype of RAS-Associated Autoimmune Leukoproliferative Disorder (RALD) Is Characterized By Single Somatic Mutations in RAS Genes with Absence of Cooperating Mutations. Blood. 2016; 128: 4268\u20134268.","DOI":"10.1182\/blood.V128.22.4268.4268."},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Leon-Cabrera S, V\u00e1zquez-Sandoval A, Molina-Guzman E, Delgado-Ramirez Y, Delgado-Buenrostro NL, Callejas BE, et al. Deficiency in STAT1 Signaling Predisposes Gut Inflammation and Prompts Colorectal Cancer Development. Cancers. 2018; 10: 341.","DOI":"10.3390\/cancers10090341."},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LAB, Gilissen C, et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. The New England Journal of Medicine. 2011; 365: 54\u201361.","DOI":"10.1056\/NEJMoa1100102."},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Hambleton S, Goodbourn S, Young DF, Dickinson P, Mohamad SMB, Valappil M, et al. STAT2 deficiency and susceptibility to viral illness in humans. Proceedings of the National Academy of Sciences of the United States of America. 2013; 110: 3053\u20133058.","DOI":"10.1073\/pnas.1220098110."},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Zhu G, Badonyi M, Franklin L, Seabra L, Rice GI, Anne-Boland-Auge, et al. Type I Interferonopathy due to a Homozygous Loss-of-Inhibitory Function Mutation in STAT2. Journal of Clinical Immunology. 2023; 43: 808\u2013818.","DOI":"10.1007\/s10875-023-01445-3."},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Moens L, Van Eyck L, Jochmans D, Mitera T, Frans G, Bossuyt X, et al. A novel kindred with inherited STAT2 deficiency and severe viral illness. The Journal of Allergy and Clinical Immunology. 2017; 139: 1995\u20131997.e9.","DOI":"10.1016\/j.jaci.2016.10.033."},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Flanagan SE, Haapaniemi E, Russell MA, Caswell R, Allen HL, De Franco E, et al. Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease. Nature Genetics. 2014; 46: 812\u2013814.","DOI":"10.1038\/ng.3040."},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nature Reviews. Cancer. 2009; 9: 798\u2013809.","DOI":"10.1038\/nrc2734."},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Kaneko S, Sakura F, Tanita K, Shimbo A, Nambu R, Yoshida M, et al. Janus kinase inhibitors ameliorate clinical symptoms in patients with STAT3 gain-of-function. Immunotherapy Advances. 2023; 3: ltad027.","DOI":"10.1093\/immadv\/ltad027."},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nature Reviews. Clinical Oncology. 2018; 15: 234\u2013248.","DOI":"10.1038\/nrclinonc.2018.8."},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Huang B, Lang X, Li X. The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers. Frontiers in Oncology. 2022; 12: 1023177.","DOI":"10.3389\/fonc.2022.1023177."},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Harrison SC, Tsilifis C, Slatter MA, Nademi Z, Worth A, Veys P, et al. Hematopoietic Stem Cell Transplantation Resolves the Immune Deficit Associated with STAT3-Dominant-Negative Hyper-IgE Syndrome. Journal of Clinical Immunology. 2021; 41: 934\u2013943.","DOI":"10.1007\/s10875-021-00971-2."},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Ponsford MJ, Clark J, Mock J, Abinun M, Carne E, El-Shanawany T, et al. Hematopoietic Stem Cell Transplantation and Vasculopathy Associated With STAT3-Dominant-Negative Hyper-IgE Syndrome. Frontiers in Pediatrics. 2020; 8: 575.","DOI":"10.3389\/fped.2020.00575."},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Freeman AF, Holland SM. The hyper-IgE syndromes. Immunology and Allergy Clinics of North America. 2008; 28: 277\u201391, viii.","DOI":"10.1016\/j.iac.2008.01.005."},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Chandesris MO, Melki I, Natividad A, Puel A, Fieschi C, Yun L, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine. 2012; 91: e1\u2013e19.","DOI":"10.1097\/MD.0b013e31825f95b9."},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Woellner C, Gertz EM, Sch\u00e4ffer AA, Lagos M, Perro M, Glocker EO, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. The Journal of Allergy and Clinical Immunology. 2010; 125: 424\u2013432.e8.","DOI":"10.1016\/j.jaci.2009.10.059."},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Shaheen M, Broxmeyer HE. Chapter 16 - Cytokine\/Receptor Families and Signal Transduction. In Hoffman R, Benz EJ, Silberstein LE, et al. (eds.) Hematology (Seventh Edition) (pp. 163\u2013175). Elsevier: the Netherlands. 2018.","DOI":"10.1016\/B978-0-323-35762-3.00016-0"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Sigurdsson S, Nordmark G, Garnier S, Grundberg E, Kwan T, Nilsson O, et al. A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. Human Molecular Genetics. 2008; 17: 2868\u20132876.","DOI":"10.1093\/hmg\/ddn184."},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Debierre-Grockiego F. Anti-apoptotic role of STAT5 in haematopoietic cells and in the pathogenesis of malignancies. Apoptosis: an International Journal on Programmed Cell Death. 2004; 9: 717\u2013728.","DOI":"10.1023\/B:APPT.0000045785.65546.a2."},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Bandapalli OR, Schuessele S, Kunz JB, Rausch T, St\u00fctz AM, Tal N, et al. The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse. Haematologica. 2014; 99: e188\u2013e192.","DOI":"10.3324\/haematol.2014.104992."},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Eisenberg R, Gans MD, Leahy TR, Gothe F, Perry C, Raffeld M, et al. JAK inhibition in early-onset somatic, nonclonal STAT5B gain-of-function disease. The Journal of Allergy and Clinical Immunology. in Practice. 2021; 9: 1008\u20131010.e2.","DOI":"10.1016\/j.jaip.2020.11.050."},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Dorritie KA, McCubrey JA, Johnson DE. STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention. Leukemia. 2014; 28: 248\u2013257.","DOI":"10.1038\/leu.2013.192."},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Hwa V. STAT5B deficiency: Impacts on human growth and immunity. Growth Hormone & IGF Research: Official Journal of the Growth Hormone Research Society and the International IGF Research Society. 2016; 28: 16\u201320.","DOI":"10.1016\/j.ghir.2015.12.006."},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Sharma M, Leung D, Momenilandi M, Jones LCW, Pacillo L, James AE, et al. Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease. The Journal of Experimental Medicine. 2023; 220: e20221755.","DOI":"10.1084\/jem.20221755."},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Minskaia E, Maimaris J, Jenkins P, Albuquerque AS, Hong Y, Eleftheriou D, et al. Autosomal Dominant STAT6 Gain of Function Causes Severe Atopy Associated with Lymphoma. Journal of Clinical Immunology. 2023; 43: 1611\u20131622.","DOI":"10.1007\/s10875-023-01530-7."},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Del Bel KL, Ragotte RJ, Saferali A, Lee S, Vercauteren SM, Mostafavi SA, et al. JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome. The Journal of Allergy and Clinical Immunology. 2017; 139: 2016\u20132020.e5.","DOI":"10.1016\/j.jaci.2016.12.957."},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Gruber CN, Calis JJA, Buta S, Evrony G, Martin JC, Uhl SA, et al. Complex Autoinflammatory Syndrome Unveils Fundamental Principles of JAK1 Kinase Transcriptional and Biochemical Function. Immunity. 2020; 53: 672\u2013684.e11.","DOI":"10.1016\/j.immuni.2020.07.006."},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Daza-Cajigal V, Albuquerque AS, Young DF, Ciancanelli MJ, Moulding D, Angulo I, et al. Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria. Frontiers in Immunology. 2022; 13: 888427.","DOI":"10.3389\/fimmu.2022.888427."},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Torres DG, Paes J, da Costa AG, Malheiro A, Silva GV, Mour\u00e3o LPDS, et al. JAK2 Variant Signaling: Genetic, Hematologic and Immune Implication in Chronic Myeloproliferative Neoplasms. Biomolecules. 2022; 12: 291.","DOI":"10.3390\/biom12020291."},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Li J, Kent DG, Chen E, Green AR. Mouse models of myeloproliferative neoplasms: JAK of all grades. Disease Models & Mechanisms. 2011; 4: 311\u2013317.","DOI":"10.1242\/dmm.006817."},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Lesmana H, Popescu M, Lewis S, Sahoo SS, Goodings-Harris C, Onciu M, et al. Germline Gain-of-Function JAK3 Mutation in Familial Chronic Lymphoproliferative Disorder of NK Cells. Blood. 2020; 136: 9\u201310.","DOI":"10.1182\/blood-2020-142078."},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Hadjadj J, Castro CN, Tusseau M, Stolzenberg MC, Mazerolles F, Aladjidi N, et al. Early-onset autoimmunity associated with SOCS1 haploinsufficiency. Nature Communications. 2020; 11: 5341.","DOI":"10.1038\/s41467-020-18925-4."},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Grimbacher B, Warnatz K, Yong PFK, Korganow AS, Peter HH. The crossroads of autoimmunity and immunodeficiency: Lessons from polygenic traits and monogenic defects. The Journal of Allergy and Clinical Immunology. 2016; 137: 3\u201317.","DOI":"10.1016\/j.jaci.2015.11.004."},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Alsohime F, Martin-Fernandez M, Temsah MH, Alabdulhafid M, Le Voyer T, Alghamdi M, et al. JAK Inhibitor Therapy in a Child with Inherited USP18 Deficiency. The New England Journal of Medicine. 2020; 382: 256\u2013265.","DOI":"10.1056\/NEJMoa1905633."},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Meuwissen MEC, Schot R, Buta S, Oudesluijs G, Tinschert S, Speer SD, et al. Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome. The Journal of Experimental Medicine. 2016; 213: 1163\u20131174.","DOI":"10.1084\/jem.20151529."},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Mukai T, Waki K. X-linked lymphoproliferative syndrome associated with Epstein-Barr virus encephalitis and lymphoproliferative disorder. Clinical Case Reports. 2023; 11: e7949.","DOI":"10.1002\/ccr3.7949."},{"key":"ref59","unstructured":"Diseases NIoAaI. X-linked lymphoproliferative disease. (n.d.)."},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Lorenzini T, Dotta L, Giacomelli M, Vairo D, Badolato R. STAT mutations as program switchers: turning primary immunodeficiencies into autoimmune diseases. Journal of Leukocyte Biology. 2017; 101: 29\u201338.","DOI":"10.1189\/jlb.5RI0516-237RR."},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Nevado M, Gonz\u00e1lez-Granado LI, Ruiz-Garc\u00eda R, Pleguezuelo D, Cabrera-Marante O, Salm\u00f3n N, et al. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. Frontiers in Immunology. 2021; 12: 671755.","DOI":"10.3389\/fimmu.2021.671755."},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Rieux-Laucat F, Mag\u00e9rus-Chatinet A, Neven B. The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions. Journal of Clinical Immunology. 2018; 38: 558\u2013568.","DOI":"10.1007\/s10875-018-0523-x."},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Consonni F, Gambineri E, Favre C. ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies. Annals of Hematology. 2022; 101: 469\u2013484.","DOI":"10.1007\/s00277-022-04761-7."},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Tsilifis C, Slatter MA, Gennery AR. Too much of a good thing: a review of primary immune regulatory disorders. Frontiers in Immunology. 2023; 14: 1279201.","DOI":"10.3389\/fimmu.2023.1279201."},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Palmisani E, Miano M, Grossi A, Lanciotti M, Lupia M, Terranova P, et al. Autoimmune Lymphoproliferative Syndrome (ALPS) Disease and ALPS Phenotype: Are They Two Distinct Entities? HemaSphere. 2023; 7: e845.","DOI":"10.1097\/HS9.0000000000000845."},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Miano M, Cappelli E, Pezzulla A, Ven\u00e8 R, Grossi A, Terranova P, et al. FAS-mediated apoptosis impairment in patients with ALPS\/ALPS-like phenotype carrying variants on CASP10 gene. British Journal of Haematology. 2019; 187: 502\u2013508.","DOI":"10.1111\/bjh.16098."},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Feito A, Melero J, Mora-D\u00edaz S, Rodr\u00edguez-Vigil C, Elduayen R, Gonz\u00e1lez-Granado LI, et al. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation. Immunobiology. 2016; 221: 40\u201347.","DOI":"10.1016\/j.imbio.2015.08.004."},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Consonni F, Moreno S, Vinuales Colell B, Stolzenberg MC, Fernandes A, Parisot M, et al. Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome. Cell Death & Disease. 2024; 15: 315.","DOI":"10.1038\/s41419-024-06679-6."},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Bride K, Teachey D. Autoimmune lymphoproliferative syndrome: more than a FAScinating disease. F1000Research. 2017; 6: 1928.","DOI":"10.12688\/f1000research.11545.1."},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Price S, Shaw PA, Seitz A, Joshi G, Davis J, Niemela JE, et al. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood. 2014; 123: 1989\u20131999.","DOI":"10.1182\/blood-2013-10-535393."},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Su\u00e1rez-Guti\u00e9rrez M, Yamazaki-Nakashimada MA, Espinosa S, Blancas-Galicia L, Lugo-Reyes SO, \u00c1lvarez-Cardona A. Autoimmune lymphoproliferative syndrome. Update and review. Revista Alergia Mexico (Tecamachalco, Puebla, Mexico: 1993). 2019; 66: 456\u2013473.","DOI":"10.29262\/ram.v66i4.646."},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Li X, Li F, Zhang X, Zhang H, Zhao Q, Li M, et al. Caspase-8 auto-cleavage regulates programmed cell death and collaborates with RIPK3\/MLKL to prevent lymphopenia. Cell Death and Differentiation. 2022; 29: 1500\u20131512.","DOI":"10.1038\/s41418-022-00938-9."},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Gitlin AD, Heger K, Schubert AF, Reja R, Yan D, Pham VC, et al. Integration of innate immune signalling by caspase-8 cleavage of N4BP1. Nature. 2020; 587: 275\u2013280.","DOI":"10.1038\/s41586-020-2796-5."},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Calvo KR, Price S, Braylan RC, Oliveira JB, Lenardo M, Fleisher TA, et al. JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities. Blood. 2015; 125: 2753\u20132758.","DOI":"10.1182\/blood-2014-11-567917."},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Luciano F, Jacquel A, Colosetti P, Herrant M, Cagnol S, Pages G, et al. Phosphorylation of Bim-EL by Erk1\/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. Oncogene. 2003; 22: 6785\u20136793.","DOI":"10.1038\/sj.onc.1206792."},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Aguilar C, Latour S. X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome. Journal of Clinical Immunology. 2015; 35: 331\u2013338.","DOI":"10.1007\/s10875-015-0141-9."},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Xu T, Zhao Q, Li W, Chen X, Xue X, Chen Z, et al. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic. European Journal of Pediatrics. 2020; 179: 327\u2013338.","DOI":"10.1007\/s00431-019-03512-7."},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Veillette A, P\u00e9rez-Quintero LA, Latour S. X-linked lymphoproliferative syndromes and related autosomal recessive disorders. Current Opinion in Allergy and Clinical Immunology. 2013; 13: 614\u2013622.","DOI":"10.1097\/ACI.0000000000000008."},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Rezaei N, Mahmoudi E, Aghamohammadi A, Das R, Nichols KE. X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma. British Journal of Haematology. 2011; 152: 13\u201330.","DOI":"10.1111\/j.1365-2141.2010.08442.x."},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Pachlopnik Schmid J, Canioni D, Moshous D, Touzot F, Mahlaoui N, Hauck F, et al. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1\/SAP deficiency) versus type 2 (XLP-2\/XIAP deficiency). Blood. 2011; 117: 1522\u20131529.","DOI":"10.1182\/blood-2010-07-298372."},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Palendira U, Low C, Bell AI, Ma CS, Abbott RJM, Phan TG, et al. Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus. The Journal of Experimental Medicine. 2012; 209: 913\u2013924.","DOI":"10.1084\/jem.20112391."},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Narahari PG, Gebbia J, Alperstein W, Kleiner G, Gans M. Post-SARS-CoV-2 Atypical Inflammatory Syndrome in a Toddler with X-Linked Inhibitor of Apoptosis Deficiency After Stem Cell Transplant. Journal of Clinical Immunology. 2022; 42: 1600\u20131603.","DOI":"10.1007\/s10875-022-01316-3."},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Sarrafzadeh SA, Mahloojirad M, Casanova JL, Badalzadeh M, Bustamante J, Boisson-Dupuis S, et al. A New Patient with Inherited TYK2 Deficiency. Journal of Clinical Immunology. 2020; 40: 232\u2013235.","DOI":"10.1007\/s10875-019-00713-5."},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"D\u2019Souza WN, Lefran\u00e7ois L. IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion. The Journal of Immunology. 2003; 171: 5727\u20135735.","DOI":"10.4049\/jimmunol.171.11.5727."},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Mazewski C, Perez RE, Fish EN, Platanias LC. Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways. Frontiers in Immunology. 2020; 11: 606456.","DOI":"10.3389\/fimmu.2020.606456."},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Shahni R, Cale CM, Anderson G, Osellame LD, Hambleton S, Jacques TS, et al. Signal transducer and activator of transcription 2 deficiency is a novel disorder of mitochondrial fission. Brain: a Journal of Neurology. 2015; 138: 2834\u20132846.","DOI":"10.1093\/brain\/awv182."},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Bucciol G, Moens L, Ogishi M, Rinchai D, Matuozzo D, Momenilandi M, et al. Human inherited complete STAT2 deficiency underlies inflammatory viral diseases. The Journal of Clinical Investigation. 2023; 133: e168321.","DOI":"10.1172\/JCI168321."},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Nevado M, Sevilla J, Almendro-V\u00e1zquez P, Gil-Etayo FJ, Garcinu\u00f1o S, Serrano-Hern\u00e1ndez A, et al. Inborn Error of STAT2-Dependent IFN-I Immunity in a Patient Presented with Hemophagocytic Lymphohistiocytosis and Multisystem Inflammatory Syndrome in Children. Journal of Clinical Immunology. 2023; 43: 1278\u20131288.","DOI":"10.1007\/s10875-023-01488-6."},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Zhang X, Wang Y, Lv J. STAT4 targets KISS1 to inhibit the oxidative damage, inflammation and neuronal apoptosis in experimental PD models by inactivating the MAPK pathway. Neurochemistry International. 2024; 175: 105683.","DOI":"10.1016\/j.neuint.2024.105683."},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Yang C, Mai H, Peng J, Zhou B, Hou J, Jiang D. STAT4: an immunoregulator contributing to diverse human diseases. International Journal of Biological Sciences. 2020; 16: 1575\u20131585.","DOI":"10.7150\/ijbs.41852."},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"Baghdassarian H, Blackstone SA, Clay OS, Philips R, Matthiasardottir B, Nehrebecky M, et al. Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome. The New England Journal of Medicine. 2023; 388: 2241\u20132252.","DOI":"10.1056\/NEJMoa2202318."},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Fayand A, Hentgen V, Posseme C, Lacout C, Picard C, Moguelet P, et al. Successful treatment of JAK1-associated inflammatory disease. The Journal of Allergy and Clinical Immunology. 2023; 152: 972\u2013983.","DOI":"10.1016\/j.jaci.2023.06.004."},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"Biggs CM, Cordeiro-Santanach A, Prykhozhij SV, Deveau AP, Lin Y, Del Bel KL, et al. Human JAK1 gain of function causes dysregulated myelopoeisis and severe allergic inflammation. JCI Insight. 2022; 7: e150849.","DOI":"10.1172\/jci.insight.150849."},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"Takeichi T, Lee JYW, Okuno Y, Miyasaka Y, Murase Y, Yoshikawa T, et al. Autoinflammatory Keratinization Disease With Hepatitis and Autism Reveals Roles for JAK1 Kinase Hyperactivity in Autoinflammation. Frontiers in Immunology. 2022; 12: 737747.","DOI":"10.3389\/fimmu.2021.737747."},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"Rochman Y, Spolski R, Leonard WJ. New insights into the regulation of T cells by gamma(c) family cytokines. Nature Reviews. Immunology. 2009; 9: 480\u2013490.","DOI":"10.1038\/nri2580."},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"K\u00f6rholz J, Gabrielyan A, Sowerby JM, Boschann F, Chen LS, Paul D, et al. One Gene, Many Facets: Multiple Immune Pathway Dysregulation in SOCS1 Haploinsufficiency. Frontiers in Immunology. 2021; 12: 680334.","DOI":"10.3389\/fimmu.2021.680334."},{"key":"ref97","doi-asserted-by":"publisher","unstructured":"Martin-Fernandez M, Buta S, Le Voyer T, Li Z, Dynesen LT, Vuillier F, et al. A partial form of inherited human USP18 deficiency underlies infection and inflammation. The Journal of Experimental Medicine. 2022; 219: e20211273.","DOI":"10.1084\/jem.20211273."},{"key":"ref98","doi-asserted-by":"publisher","unstructured":"Neven B, Magerus-Chatinet A, Florkin B, Gobert D, Lambotte O, De Somer L, et al. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood. 2011; 118: 4798\u20134807.","DOI":"10.1182\/blood-2011-04-347641."},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"Smith TD, Doherty TA. Learning while treating: Gain-of-function STAT6 variants in severe allergic disease. Cell Reports. Medicine. 2023; 4: 101040.","DOI":"10.1016\/j.xcrm.2023.101040."},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"Zulkeflee RH, Zulkafli Z, Johan MF, Husin A, Islam MA, Hassan R. Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN). International Journal of Environmental Research and Public Health. 2021; 18: 7582.","DOI":"10.3390\/ijerph18147582."},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"Akada H, Akada S, Hutchison RE, Sakamoto K, Wagner KU, Mohi G. Critical role of Jak2 in the maintenance and function of adult hematopoietic stem cells. Stem Cells (Dayton, Ohio). 2014; 32: 1878\u20131889.","DOI":"10.1002\/stem.1711."},{"key":"ref102","doi-asserted-by":"publisher","unstructured":"Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet (London, England). 2005; 365: 1054\u20131061.","DOI":"10.1016\/S0140-6736(05)71142-9."},{"key":"ref103","doi-asserted-by":"publisher","unstructured":"Lamana A, Villares R, Seoane IV, Andr\u00e9s N, Lucas P, Emery P, et al. Identification of a Human SOCS1 Polymorphism That Predicts Rheumatoid Arthritis Severity. Frontiers in Immunology. 2020; 11: 1336.","DOI":"10.3389\/fimmu.2020.01336."},{"key":"ref104","doi-asserted-by":"publisher","unstructured":"Wang H, Wang J, Xia Y. Defective Suppressor of Cytokine Signaling 1 Signaling Contributes to the Pathogenesis of Systemic Lupus Erythematosus. Frontiers in Immunology. 2017; 8: 1292.","DOI":"10.3389\/fimmu.2017.01292."},{"key":"ref105","doi-asserted-by":"publisher","unstructured":"Bazgir N, Tahvildari A, Chavoshzade Z, Jamee M, Golchehre Z, Karimi A, et al. A rare immunological disease, caspase 8 deficiency: case report and literature review. Allergy, Asthma, and Clinical Immunology: Official Journal of the Canadian Society of Allergy and Clinical Immunology. 2023; 19: 29.","DOI":"10.1186\/s13223-023-00778-3."},{"key":"ref106","doi-asserted-by":"publisher","unstructured":"Pang J, Vince JE. The role of caspase-8 in inflammatory signalling and pyroptotic cell death. Seminars in Immunology. 2023; 70: 101832.","DOI":"10.1016\/j.smim.2023.101832."},{"key":"ref107","doi-asserted-by":"publisher","unstructured":"Neven B, Leroy S, Decaluwe H, Le Deist F, Picard C, Moshous D, et al. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood. 2009; 113: 4114\u20134124.","DOI":"10.1182\/blood-2008-09-177923."},{"key":"ref108","doi-asserted-by":"publisher","unstructured":"Stang SL, Lopez-Campistrous A, Song X, Dower NA, Blumberg PM, Wender PA, et al. A proapoptotic signaling pathway involving RasGRP, Erk, and Bim in B cells. Experimental Hematology. 2009; 37: 122\u2013134.","DOI":"10.1016\/j.exphem.2008.09.008."},{"key":"ref109","doi-asserted-by":"publisher","unstructured":"Chaimowitz NS, Smith MR, Forbes Satter LR. JAK\/STAT defects and immune dysregulation, and guiding therapeutic choices. Immunological Reviews. 2024; 322: 311\u2013328.","DOI":"10.1111\/imr.13312."},{"key":"ref110","doi-asserted-by":"publisher","unstructured":"Shimizu M, Takei S, Mori M, Yachie A. Pathogenic roles and diagnostic utility of interleukin-18 in autoinflammatory diseases. Frontiers in Immunology. 2022; 13: 951535.","DOI":"10.3389\/fimmu.2022.951535."},{"key":"ref111","doi-asserted-by":"publisher","unstructured":"Panchal N, Booth C, Cannons JL, Schwartzberg PL. X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective. Frontiers in Immunology. 2018; 9: 666.","DOI":"10.3389\/fimmu.2018.00666."},{"key":"ref112","doi-asserted-by":"publisher","unstructured":"Rigaud S, Fondan\u00e8che MC, Lambert N, Pasquier B, Mateo V, Soulas P, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006; 444: 110\u2013114.","DOI":"10.1038\/nature05257."},{"key":"ref113","doi-asserted-by":"publisher","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduction and Targeted Therapy. 2021; 6: 402.","DOI":"10.1038\/s41392-021-00791-1."},{"key":"ref114","doi-asserted-by":"publisher","unstructured":"Wilmes S, Jeffrey PA, Martinez-Fabregas J, Hafer M, Fyfe PK, Pohler E, et al. Competitive binding of STATs to receptor phospho-Tyr motifs accounts for altered cytokine responses. eLife. 2021; 10: e66014.","DOI":"10.7554\/eLife.66014."},{"key":"ref115","doi-asserted-by":"publisher","unstructured":"Petes C, Mariani MK, Yang Y, Grandvaux N, Gee K. Interleukin (IL)-6 Inhibits IL-27- and IL-30-Mediated Inflammatory Responses in Human Monocytes. Frontiers in Immunology. 2018; 9: 256.","DOI":"10.3389\/fimmu.2018.00256."},{"key":"ref116","doi-asserted-by":"publisher","unstructured":"Forbes LR, Vogel TP, Cooper MA, Castro-Wagner J, Schussler E, Weinacht KG, et al. Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations. The Journal of Allergy and Clinical Immunology. 2018; 142: 1665\u20131669.","DOI":"10.1016\/j.jaci.2018.07.020."},{"key":"ref117","doi-asserted-by":"publisher","unstructured":"Borgstr\u00f6m EW, Edvinsson M, P\u00e9rez LP, Norlin AC, Enoksson SL, Hansen S, et al. Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK Inhibitors. Journal of Clinical Immunology. 2023; 43: 136\u2013150.","DOI":"10.1007\/s10875-022-01351-0."},{"key":"ref118","doi-asserted-by":"publisher","unstructured":"Kayaoglu B, Kasap N, Yilmaz NS, Charbonnier LM, Geckin B, Akcay A, et al. Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation. Journal of Clinical Immunology. 2021; 41: 769\u2013779.","DOI":"10.1007\/s10875-020-00943-y."},{"key":"ref119","doi-asserted-by":"publisher","unstructured":"Townsend PA, Scarabelli TM, Davidson SM, Knight RA, Latchman DS, Stephanou A. STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. The Journal of Biological Chemistry. 2004; 279: 5811\u20135820.","DOI":"10.1074\/jbc.M302637200."},{"key":"ref120","doi-asserted-by":"publisher","unstructured":"Wincewicz A, Sulkowska M, Rutkowski R, Sulkowski S, Musiatowicz B, Hirnle T, et al. STAT1 and STAT3 as intracellular regulators of vascular remodeling. European Journal of Internal Medicine. 2007; 18: 267\u2013271.","DOI":"10.1016\/j.ejim.2006.12.007."},{"key":"ref121","doi-asserted-by":"publisher","unstructured":"Gruber C, Martin-Fernandez M, Ailal F, Qiu X, Taft J, Altman J, et al. Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy. The Journal of Experimental Medicine. 2020; 217: e20192319.","DOI":"10.1084\/jem.20192319."},{"key":"ref122","doi-asserted-by":"publisher","unstructured":"B\u00e9ziat V, Li J, Lin JX, Ma CS, Li P, Bousfiha A, et al. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity. Science Immunology. 2018; 3: eaat4956.","DOI":"10.1126\/sciimmunol.aat4956."},{"key":"ref123","doi-asserted-by":"publisher","unstructured":"Milner JD, Vogel TP, Forbes L, Ma CA, Stray-Pedersen A, Niemela JE, et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood. 2015; 125: 591\u2013599.","DOI":"10.1182\/blood-2014-09-602763."},{"key":"ref124","doi-asserted-by":"publisher","unstructured":"Li J, Liu YY, Yang XF, Shen DF, Sun HZ, Huang KQ, et al. Effects and mechanism of STAT3 silencing on the growth and apoptosis of colorectal cancer cells. Oncology Letters. 2018; 16: 5575\u20135582.","DOI":"10.3892\/ol.2018.9368."},{"key":"ref125","doi-asserted-by":"publisher","unstructured":"Gestermann N, Mekinian A, Comets E, Loiseau P, Puechal X, Hachulla E, et al. STAT4 is a confirmed genetic risk factor for Sj\u00f6gren\u2019s syndrome and could be involved in type 1 interferon pathway signaling. Genes and Immunity. 2010; 11: 432\u2013438.","DOI":"10.1038\/gene.2010.29."},{"key":"ref126","doi-asserted-by":"publisher","unstructured":"Casanova JL, Holland SM, Notarangelo LD. Inborn errors of human JAKs and STATs. Immunity. 2012; 36: 515\u2013528.","DOI":"10.1016\/j.immuni.2012.03.016."},{"key":"ref127","doi-asserted-by":"publisher","unstructured":"Behbod F, Nagy ZS, Stepkowski SM, Karras J, Johnson CR, Jarvis WD, et al. Specific inhibition of Stat5a\/b promotes apoptosis of IL-2-responsive primary and tumor-derived lymphoid cells. Journal of Immunology (Baltimore, Md.: 1950). 2003; 171: 3919\u20133927.","DOI":"10.4049\/jimmunol.171.8.3919."},{"key":"ref128","doi-asserted-by":"publisher","unstructured":"Ott N, Faletti L, Heeg M, Andreani V, Grimbacher B. JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences. Journal of Clinical Immunology. 2023; 43: 1326\u20131359.","DOI":"10.1007\/s10875-023-01483-x."},{"key":"ref129","doi-asserted-by":"publisher","unstructured":"Eletto D, Burns SO, Angulo I, Plagnol V, Gilmour KC, Henriquez F, et al. Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection. Nature Communications. 2016; 7: 13992.","DOI":"10.1038\/ncomms13992."},{"key":"ref130","doi-asserted-by":"publisher","unstructured":"Sic H, Speletas M, Cornacchione V, Seidl M, Beibel M, Linghu B, et al. An Activating Janus Kinase-3 Mutation Is Associated with Cytotoxic T Lymphocyte Antigen-4-Dependent Immune Dysregulation Syndrome. Frontiers in Immunology. 2017; 8: 1824.","DOI":"10.3389\/fimmu.2017.01824."},{"key":"ref131","doi-asserted-by":"publisher","unstructured":"Chang CW, Lai YS, Westin E, Khodadadi-Jamayran A, Pawlik KM, Lamb LS, Jr, et al. Modeling Human Severe Combined Immunodeficiency and Correction by CRISPR\/Cas9-Enhanced Gene Targeting. Cell Reports. 2015; 12: 1668\u20131677.","DOI":"10.1016\/j.celrep.2015.08.013."},{"key":"ref132","doi-asserted-by":"publisher","unstructured":"Surh CD, Sprent J. Homeostasis of naive and memory T cells. Immunity. 2008; 29: 848\u2013862.","DOI":"10.1016\/j.immuni.2008.11.002."},{"key":"ref133","doi-asserted-by":"publisher","unstructured":"Mazzucchelli R, Durum SK. Interleukin-7 receptor expression: intelligent design. Nature Reviews. Immunology. 2007; 7: 144\u2013154.","DOI":"10.1038\/nri2023."},{"key":"ref134","doi-asserted-by":"publisher","unstructured":"Notarangelo LD, Mella P, Jones A, de Saint Basile G, Savoldi G, Cranston T, et al. Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency. Human Mutation. 2001; 18: 255\u2013263.","DOI":"10.1002\/humu.1188."},{"key":"ref135","unstructured":"Database THG. TNF Superfamily Member 12. Gene Cards. Oct 2, 2024 2024; Protein Coding (GC17P132657) (Tumor necrosis factor superfamily)."},{"key":"ref136","doi-asserted-by":"publisher","unstructured":"Burkly LC. Regulation of Tissue Responses: The TWEAK\/Fn14 Pathway and Other TNF\/TNFR Superfamily Members That Activate Non-Canonical NF\u03baB Signaling. Frontiers in Immunology. 2015; 6: 92.","DOI":"10.3389\/fimmu.2015.00092."},{"key":"ref137","doi-asserted-by":"publisher","unstructured":"Liao L, Li S, Upreti B, Wang X, Yang Y, Lou X, et al. Status of TWEAK DNA methylation and mRNA expression in systemic lupus erythematosus. Lupus. 2023; 32: 171\u2013179.","DOI":"10.1177\/09612033221141261."},{"key":"ref138","doi-asserted-by":"publisher","unstructured":"Cheng E, Armstrong CL, Galisteo R, Winkles JA. TWEAK\/Fn14 Axis-Targeted Therapeutics: Moving Basic Science Discoveries to the Clinic. Frontiers in Immunology. 2013; 4: 473.","DOI":"10.3389\/fimmu.2013.00473."},{"key":"ref139","doi-asserted-by":"publisher","unstructured":"Chen DY, Chen YM, Lin CF, Lo CM, Liu HJ, Liao TL. MicroRNA-889 Inhibits Autophagy To Maintain Mycobacterial Survival in Patients with Latent Tuberculosis Infection by Targeting TWEAK. mBio. 2020; 11: e03045\u201319.","DOI":"10.1128\/mBio.03045-19."},{"key":"ref140","doi-asserted-by":"publisher","unstructured":"Yal\u00e7\u0131n Kehribar D, Cihangiro\u011flu M, Sehmen E, Avc\u0131 B, \u00c7apraz M, Boran M, et al. The assessment of the serum levels of TWEAK and prostaglandin F2\u03b1 in COVID \u2013 19. Turkish Journal of Medical Sciences. 2020; 50: 1786\u20131791.","DOI":"10.3906\/sag-2006-96."},{"key":"ref141","doi-asserted-by":"publisher","unstructured":"Ab\u00f3s B, P\u00e9rez-Fern\u00e1ndez E, Morel E, Perdiguero P, Tafalla C. Pro-Inflammatory and B Cell Regulating Capacities of TWEAK in Rainbow Trout (Oncorhynchus mykiss). Frontiers in Immunology. 2021; 12: 748836.","DOI":"10.3389\/fimmu.2021.748836."},{"key":"ref142","doi-asserted-by":"publisher","unstructured":"Michaelson JS, Wisniacki N, Burkly LC, Putterman C. Role of TWEAK in lupus nephritis: a bench-to-bedside review. Journal of Autoimmunity. 2012; 39: 130\u2013142.","DOI":"10.1016\/j.jaut.2012.05.003."},{"key":"ref143","doi-asserted-by":"publisher","unstructured":"Castagnoli R, Notarangelo LD. Updates on new monogenic inborn errors of immunity. Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology. 2020; 31 Suppl 26: 57\u201359.","DOI":"10.1111\/pai.13365."},{"key":"ref144","doi-asserted-by":"publisher","unstructured":"Wang W, Lopez McDonald MC, Kim C, Ma M, Pan ZT, Kaufmann C, et al. The complementary roles of STAT3 and STAT1 in cancer biology: insights into tumor pathogenesis and therapeutic strategies. Frontiers in Immunology. 2023; 14: 1265818.","DOI":"10.3389\/fimmu.2023.1265818."}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/30\/5\/10.31083\/FBL27231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:33:11Z","timestamp":1749040391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/30\/5\/10.31083\/FBL27231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":144,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"alternative-id":["S2768-6701(24)01608-3"],"URL":"https:\/\/doi.org\/10.31083\/fbl27231","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"article-number":"27231"}}